相关实验视频

Updated: Jul 7, 2025

Modified Laparoscopic Anatomic Hepatectomy: Two-Surgeon Technique Combined with the Simple Extracorporeal Pringle Maneuver

Modified Laparoscopic Anatomic Hepatectomy: Two-Surgeon Technique Combined with the Simple Extracorporeal Pringle Maneuver

Published on: June 16, 2023

流体治疗对非糖尿病患者进行 laparoscopy 的血糖变化的影响

João Barbosa¹, Maria Valentim¹, Mariana Almeida¹

¹Anesthesiology Department, Hospital de Braga, Braga, PRT.

|December 25, 2023

概括

在接受腹腔镜手术的非糖尿病患者中,手术期间的液体选择不会显著影响血糖水平. 这一发现表明,在不损害患者在术后期的安全性的情况下,有可能优化资源.

科学领域:

麻醉学麻醉学
代谢过程中的代谢.
手术护理手术护理

背景情况:

高血糖症增加了外科手术期间的风险.
手术应激反应会导致胰岛素抵抗.
外科手术期间流体管理对血糖变化的影响还未得到充分研究.

研究的目的:

为了研究不同类型的手术内流体对进行腹腔镜手术的非糖尿病患者血糖变化的影响.
为了比较多电解质溶液与5%的葡萄糖多电解质溶液.

主要方法:

这是一项对42名非糖尿病患者的观察性前性队列研究.
患者根据手术内液分为两组:多电解液或5%葡萄糖多电解液.
在整个外科手术期间,监测血糖水平.

主要成果:

群体之间的人口统计数据或基线特征没有显著差异.
聚乙醇和5%葡萄糖聚乙醇组之间的血糖变化没有显著差异.
随着时间的推移,血糖呈现出统计学上显著的变化,但这在两个液体组中都是一致的.

结论:

在非糖尿病患者的腹腔镜手术中使用5%的葡萄糖聚电解质 (ASA身体状况≤3) 与聚电解质相比,不会显著改变血糖变化.
这些发现支持潜在的资源优化和废物减少在外科手术期间的流体管理,而不会影响患者的平衡.

关键词:

选择性外科手术是一种选择性手术.流体疗法是一种流体疗法.糖分的变化糖分的变化过高血糖症 (hyperglycemia) 是一种腹腔镜外科手术腹腔镜外科手术

更多相关视频

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Published on: April 19, 2022

相关概念视频

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...